Dr. Jacqueline Lui, Managing Director of Eagle IP Limited, gave a talk on “Introduction to Patent Protection” at The Chinese University of Hong Kong.
我們過去活動
Recommended Insights
First Ever Successful Invalidation Challenge Due to Unauthorized Foreign Filing
2023年3月8日What does an invention “completed” in China mean? China and the US are similar in that both countries highly value national security, and thus have rules regulating the exportation of technology and information from within their borders. This includes new inventions that arise from within their respective borders. As such, both governments require inventors who […]
閱讀更多 >
A Detailed Dive into China’s New Patent Term Extension Provisions
2020年12月11日This article is a part of a larger article that highlights the newest draft implementation rules of the new Chinese Patent Law. This particular article takes a detailed dive into the patent term extension/adjustment provisions. One of the biggest and most exciting provisions in the newly amended patent law is patent term extension for delay […]
閱讀更多 >
SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit
2022年7月4日On 28 Feb 2022, China’s Supreme People’s Court (SPC) issued its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in 2021. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]
閱讀更多 >
Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data
2024年6月27日Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]
閱讀更多 >